Announcement on the Renewal of the Wholly-owned Subsidiary's Drug in the Catalogue of Drugs for Basic National Medical Insurance (2024)

About this update from Xizang Weixinkang Pharmaceutical Co., Ltd. Class A

Announcement on the Renewal of the Wholly-owned Subsidiary's Drug in the Catalogue of Drugs for Basic National Medical Insurance (2024) The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Xizang Weixinkang Pharmaceutical Co., Ltd. Class A